{"data":[{"accessionNo":"0001140361-26-036327","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-09-03","reportingPerson":"ING Capital Markets LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-11"},{"accessionNo":"0001140361-26-036327","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-09-03","reportingPerson":"ING Groep N.V.","reportingCik":null,"personType":"HC","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-09-11"},{"accessionNo":"0001104659-26-105941","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-31","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":5257389,"percentOfClass":14,"filedAt":"2026-09-08"},{"accessionNo":"0001104659-26-105941","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-31","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":5257389,"percentOfClass":14,"filedAt":"2026-09-08"},{"accessionNo":"0000315066-26-002289","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS INC","ticker":"TENX","cusip":"88032L605","securityClass":"COMMON STOCK","eventDate":"2026-08-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":514925,"percentOfClass":1.4,"filedAt":"2026-09-08"},{"accessionNo":"0000315066-26-002289","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS INC","ticker":"TENX","cusip":"88032L605","securityClass":"COMMON STOCK","eventDate":"2026-08-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":514925,"percentOfClass":1.4,"filedAt":"2026-09-08"},{"accessionNo":"0001140361-26-034749","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-19","reportingPerson":"ING Capital Markets LLC","reportingCik":null,"personType":"OO","sharesOwned":2639666,"percentOfClass":7.05,"filedAt":"2026-08-27"},{"accessionNo":"0001140361-26-034749","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-19","reportingPerson":"ING Groep N.V.","reportingCik":null,"personType":"HC","sharesOwned":2639666,"percentOfClass":7.05,"filedAt":"2026-08-27"},{"accessionNo":"0001178913-26-004262","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Sphera Funds Management Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1993496,"percentOfClass":5.33,"filedAt":"2026-08-27"},{"accessionNo":"0001178913-26-004262","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Sphera Global Healthcare Management LP","reportingCik":null,"personType":"PN","sharesOwned":1993496,"percentOfClass":5.33,"filedAt":"2026-08-27"},{"accessionNo":"0001178913-26-004262","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-17","reportingPerson":"Sphera Global Healthcare GP Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1993496,"percentOfClass":5.33,"filedAt":"2026-08-27"},{"accessionNo":"0001104659-26-098450","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":2156891,"percentOfClass":5.8,"filedAt":"2026-08-18"},{"accessionNo":"0001104659-26-098450","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2156891,"percentOfClass":5.8,"filedAt":"2026-08-18"},{"accessionNo":"0001104659-26-098450","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-08-13","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2156891,"percentOfClass":5.8,"filedAt":"2026-08-18"},{"accessionNo":"0000921895-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":3110363,"percentOfClass":9.99,"filedAt":"2026-08-14"},{"accessionNo":"0000921895-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":3110363,"percentOfClass":9.99,"filedAt":"2026-08-14"},{"accessionNo":"0000921895-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":3110363,"percentOfClass":9.99,"filedAt":"2026-08-14"},{"accessionNo":"0000921895-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":3108231,"percentOfClass":9.98,"filedAt":"2026-08-14"},{"accessionNo":"0001493215-26-000159","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":2866654,"percentOfClass":9.9,"filedAt":"2026-08-14"},{"accessionNo":"0001493215-26-000159","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-06-30","reportingPerson":"RTW Investments, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2866654,"percentOfClass":9.9,"filedAt":"2026-08-14"},{"accessionNo":"0000921895-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":2966661,"percentOfClass":9.5,"filedAt":"2026-08-14"},{"accessionNo":"0000921895-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":2966661,"percentOfClass":9.5,"filedAt":"2026-08-14"},{"accessionNo":"0001213900-26-090068","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Vivo Opportunity Fund Holdings, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3458327,"percentOfClass":9,"filedAt":"2026-08-14"},{"accessionNo":"0001213900-26-090068","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Vivo Opportunity, LLC","reportingCik":null,"personType":"OO","sharesOwned":3458327,"percentOfClass":9,"filedAt":"2026-08-14"},{"accessionNo":"0001231919-26-000935","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":1574892,"percentOfClass":4.7,"filedAt":"2026-08-14"},{"accessionNo":"0001231919-26-000935","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1574892,"percentOfClass":4.7,"filedAt":"2026-08-14"},{"accessionNo":"0001231919-26-000935","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":1574892,"percentOfClass":4.7,"filedAt":"2026-08-14"},{"accessionNo":"0001231919-26-000935","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1574892,"percentOfClass":4.7,"filedAt":"2026-08-14"},{"accessionNo":"0001231919-26-000935","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":1574892,"percentOfClass":4.7,"filedAt":"2026-08-14"},{"accessionNo":"0001231919-26-000935","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":1574892,"percentOfClass":4.7,"filedAt":"2026-08-14"},{"accessionNo":"0001231919-26-000935","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":1574892,"percentOfClass":4.7,"filedAt":"2026-08-14"},{"accessionNo":"0001193125-26-352650","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":1700000,"percentOfClass":4.5,"filedAt":"2026-08-14"},{"accessionNo":"0001193125-26-352650","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":1700000,"percentOfClass":4.5,"filedAt":"2026-08-14"},{"accessionNo":"0001193125-26-352650","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1700000,"percentOfClass":4.5,"filedAt":"2026-08-14"},{"accessionNo":"0001193125-26-352960","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":1080700,"percentOfClass":2.9,"filedAt":"2026-08-14"},{"accessionNo":"0001193125-26-352960","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":1080700,"percentOfClass":2.9,"filedAt":"2026-08-14"},{"accessionNo":"0000921895-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":141570,"percentOfClass":0.5,"filedAt":"2026-08-14"},{"accessionNo":"0000921895-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":141570,"percentOfClass":0.5,"filedAt":"2026-08-14"},{"accessionNo":"0000921895-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":7,"percentOfClass":0,"filedAt":"2026-08-14"},{"accessionNo":"0000921895-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":7,"percentOfClass":0,"filedAt":"2026-08-14"},{"accessionNo":"0000919574-26-004973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":1899495,"percentOfClass":6.81,"filedAt":"2026-08-12"},{"accessionNo":"0000919574-26-004973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":1899495,"percentOfClass":6.81,"filedAt":"2026-08-12"},{"accessionNo":"0000919574-26-004973","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":1899495,"percentOfClass":6.81,"filedAt":"2026-08-12"},{"accessionNo":"0001193125-26-328603","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-07-31","reportingPerson":"Christopher Thomas Giordano","reportingCik":"0001871714","personType":"IN","sharesOwned":1690606,"percentOfClass":4.32,"filedAt":"2026-07-31"},{"accessionNo":"0002012383-26-003107","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS INC","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":1708335,"percentOfClass":6.4,"filedAt":"2026-07-30"},{"accessionNo":"0001104659-26-084723","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":876230,"percentOfClass":3.3,"filedAt":"2026-07-17"},{"accessionNo":"0001104659-26-084723","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":876230,"percentOfClass":3.3,"filedAt":"2026-07-17"},{"accessionNo":"0001104659-26-084723","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":876230,"percentOfClass":3.3,"filedAt":"2026-07-17"},{"accessionNo":"0000315066-26-001468","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS INC","ticker":"TENX","cusip":"88032L605","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":3942373,"percentOfClass":14.9,"filedAt":"2026-07-08"},{"accessionNo":"0000315066-26-001468","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS INC","ticker":"TENX","cusip":"88032L605","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":3942373,"percentOfClass":14.9,"filedAt":"2026-07-08"},{"accessionNo":"0000080255-26-000435","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS INC","ticker":"TENX","cusip":"88032L605","securityClass":"COMMON STOCK","eventDate":"2026-05-31","reportingPerson":"T. Rowe Price Associates, Inc.","reportingCik":null,"personType":"IA","sharesOwned":586990,"percentOfClass":2.2,"filedAt":"2026-06-05"},{"accessionNo":"0001104659-26-064597","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-18","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1347130,"percentOfClass":5.1,"filedAt":"2026-05-20"},{"accessionNo":"0001104659-26-064597","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-18","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1347130,"percentOfClass":5.1,"filedAt":"2026-05-20"},{"accessionNo":"0001104659-26-064597","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-05-18","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1347130,"percentOfClass":5.1,"filedAt":"2026-05-20"},{"accessionNo":"0000921895-26-001400","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":1908722,"percentOfClass":9.99,"filedAt":"2026-05-15"},{"accessionNo":"0000921895-26-001400","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":1908722,"percentOfClass":9.99,"filedAt":"2026-05-15"},{"accessionNo":"0000921895-26-001400","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":1908722,"percentOfClass":9.99,"filedAt":"2026-05-15"},{"accessionNo":"0000921895-26-001400","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":1904255,"percentOfClass":9.97,"filedAt":"2026-05-15"},{"accessionNo":"0001493215-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":1867630,"percentOfClass":9.9,"filedAt":"2026-05-15"},{"accessionNo":"0001493215-26-000124","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"RTW Investments, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":1867630,"percentOfClass":9.9,"filedAt":"2026-05-15"},{"accessionNo":"0001738048-26-000054","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1955105,"percentOfClass":9.9,"filedAt":"2026-05-15"},{"accessionNo":"0001738048-26-000054","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":1955105,"percentOfClass":9.9,"filedAt":"2026-05-15"},{"accessionNo":"0001738048-26-000054","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":1955105,"percentOfClass":9.9,"filedAt":"2026-05-15"},{"accessionNo":"0001738048-26-000054","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":1955105,"percentOfClass":9.9,"filedAt":"2026-05-15"},{"accessionNo":"0001738048-26-000054","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":1955105,"percentOfClass":9.9,"filedAt":"2026-05-15"},{"accessionNo":"0001738048-26-000054","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1955105,"percentOfClass":9.9,"filedAt":"2026-05-15"},{"accessionNo":"0001738048-26-000054","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":1955105,"percentOfClass":9.9,"filedAt":"2026-05-15"},{"accessionNo":"0000921895-26-001400","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":1754719,"percentOfClass":9.2,"filedAt":"2026-05-15"},{"accessionNo":"0000921895-26-001400","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1754719,"percentOfClass":9.2,"filedAt":"2026-05-15"},{"accessionNo":"0001193125-26-226557","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":1447782,"percentOfClass":5.5,"filedAt":"2026-05-15"},{"accessionNo":"0001193125-26-226557","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":1447782,"percentOfClass":5.5,"filedAt":"2026-05-15"},{"accessionNo":"0001193125-26-226557","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1447782,"percentOfClass":5.5,"filedAt":"2026-05-15"},{"accessionNo":"0000935836-26-000280","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Stonepine Capital, L.P.","reportingCik":null,"personType":"OO","sharesOwned":975200,"percentOfClass":3.7,"filedAt":"2026-05-15"},{"accessionNo":"0000935836-26-000280","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Jon M. Plexico","reportingCik":null,"personType":"HC,IN","sharesOwned":975200,"percentOfClass":3.7,"filedAt":"2026-05-15"},{"accessionNo":"0000935836-26-000280","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Stonepine GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":975200,"percentOfClass":3.7,"filedAt":"2026-05-15"},{"accessionNo":"0000935836-26-000280","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Stonepine Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":975200,"percentOfClass":3.7,"filedAt":"2026-05-15"},{"accessionNo":"0000919574-26-003499","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":533965,"percentOfClass":3.1,"filedAt":"2026-05-15"},{"accessionNo":"0000919574-26-003499","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":533965,"percentOfClass":3.1,"filedAt":"2026-05-15"},{"accessionNo":"0000919574-26-003499","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":533965,"percentOfClass":3.1,"filedAt":"2026-05-15"},{"accessionNo":"0000935836-26-000286","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Logos Global Management GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":800000,"percentOfClass":3,"filedAt":"2026-05-15"},{"accessionNo":"0000935836-26-000286","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Arsani William","reportingCik":null,"personType":"HC,IN","sharesOwned":800000,"percentOfClass":3,"filedAt":"2026-05-15"},{"accessionNo":"0000935836-26-000286","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Logos GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":800000,"percentOfClass":3,"filedAt":"2026-05-15"},{"accessionNo":"0000935836-26-000286","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Logos Global Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":800000,"percentOfClass":3,"filedAt":"2026-05-15"},{"accessionNo":"0000935836-26-000286","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Logos Global Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":800000,"percentOfClass":3,"filedAt":"2026-05-15"},{"accessionNo":"0001943462-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":null,"reportingPerson":"Dellora Investments LP","reportingCik":null,"personType":"IA,HC","sharesOwned":394665,"percentOfClass":2.3,"filedAt":"2026-05-15"},{"accessionNo":"0001943462-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":null,"reportingPerson":"Kevin Pyun","reportingCik":null,"personType":"IN,HC","sharesOwned":394665,"percentOfClass":2.3,"filedAt":"2026-05-15"},{"accessionNo":"0001943462-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":null,"reportingPerson":"Dellora Investments Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":345257,"percentOfClass":2,"filedAt":"2026-05-15"},{"accessionNo":"0000921895-26-001400","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":149536,"percentOfClass":0.9,"filedAt":"2026-05-15"},{"accessionNo":"0000921895-26-001400","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":149536,"percentOfClass":0.9,"filedAt":"2026-05-15"},{"accessionNo":"0000929638-26-001902","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Lind Global Partners II LLC","reportingCik":null,"personType":"OO","sharesOwned":202480,"percentOfClass":0.78,"filedAt":"2026-05-15"},{"accessionNo":"0000929638-26-001902","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"EASTON JEFF","reportingCik":null,"personType":"IN","sharesOwned":202480,"percentOfClass":0.78,"filedAt":"2026-05-15"},{"accessionNo":"0000929638-26-001902","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Lind Global Fund II LP","reportingCik":null,"personType":"PN","sharesOwned":202480,"percentOfClass":0.78,"filedAt":"2026-05-15"},{"accessionNo":"0000921895-26-001400","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15"},{"accessionNo":"0000921895-26-001400","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-15"},{"accessionNo":"0001104659-26-058085","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":533889,"percentOfClass":2.1,"filedAt":"2026-05-08"},{"accessionNo":"0001104659-26-058085","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":533889,"percentOfClass":2.1,"filedAt":"2026-05-08"},{"accessionNo":"0001104659-26-058085","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":533889,"percentOfClass":2.1,"filedAt":"2026-05-08"},{"accessionNo":"0001104659-26-058085","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":448475,"percentOfClass":1.7,"filedAt":"2026-05-08"},{"accessionNo":"0000080255-26-000376","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS INC","ticker":"TENX","cusip":"88032L605","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"T. Rowe Price Associates, Inc.","reportingCik":null,"personType":"IA","sharesOwned":2951116,"percentOfClass":17.2,"filedAt":"2026-05-07"},{"accessionNo":"0000080255-26-000378","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS INC","ticker":"TENX","cusip":"88032L605","securityClass":"COMMON STOCK","eventDate":"2026-04-30","reportingPerson":"T. Rowe Price Associates, Inc.","reportingCik":null,"personType":"IA","sharesOwned":2841114,"percentOfClass":11,"filedAt":"2026-05-07"},{"accessionNo":"0002005369-26-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Raymond Debbane","reportingCik":null,"personType":"IN","sharesOwned":427141,"percentOfClass":2.5,"filedAt":"2026-05-04"},{"accessionNo":"0002005369-26-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Siren, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":366143,"percentOfClass":2.1,"filedAt":"2026-05-04"},{"accessionNo":"0002005369-26-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Invus Public Equities, L.P.","reportingCik":null,"personType":"PN","sharesOwned":366143,"percentOfClass":2.1,"filedAt":"2026-05-04"},{"accessionNo":"0002005369-26-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Invus Public Equities Advisors, LLC","reportingCik":null,"personType":"OO","sharesOwned":366143,"percentOfClass":2.1,"filedAt":"2026-05-04"},{"accessionNo":"0002005369-26-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Invus Global Management, LLC","reportingCik":null,"personType":"OO","sharesOwned":366143,"percentOfClass":2.1,"filedAt":"2026-05-04"},{"accessionNo":"0002005369-26-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Ulys, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":60998,"percentOfClass":0.4,"filedAt":"2026-05-04"},{"accessionNo":"0002005369-26-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Avicenna Life Sci Master GP LLC","reportingCik":null,"personType":"OO","sharesOwned":60998,"percentOfClass":0.4,"filedAt":"2026-05-04"},{"accessionNo":"0002005369-26-000029","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Avicenna Life Sci Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":60998,"percentOfClass":0.4,"filedAt":"2026-05-04"},{"accessionNo":"0000895421-26-000106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":596564,"percentOfClass":3.5,"filedAt":"2026-04-08"},{"accessionNo":"0000895421-26-000106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Morgan Stanley Capital Services LLC","reportingCik":null,"personType":"BD,CO","sharesOwned":583297,"percentOfClass":3.4,"filedAt":"2026-04-08"},{"accessionNo":"0001193125-26-146040","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":1145100,"percentOfClass":6.7,"filedAt":"2026-04-07"},{"accessionNo":"0001193125-26-146040","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":"88032L605","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":1145100,"percentOfClass":6.7,"filedAt":"2026-04-07"},{"accessionNo":"0001654954-26-002112","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-10","reportingPerson":"Christopher Thomas Giordano","reportingCik":"0001871714","personType":"IN","sharesOwned":1252965,"percentOfClass":6.79,"filedAt":"2026-03-10"},{"accessionNo":"0000935836-26-000148","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock","eventDate":"2026-02-27","reportingPerson":"Logos Global Management GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":615000,"percentOfClass":9.9,"filedAt":"2026-03-09"},{"accessionNo":"0000935836-26-000148","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock","eventDate":"2026-02-27","reportingPerson":"Arsani William","reportingCik":null,"personType":"HC,IN","sharesOwned":615000,"percentOfClass":9.9,"filedAt":"2026-03-09"},{"accessionNo":"0000935836-26-000148","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock","eventDate":"2026-02-27","reportingPerson":"Logos GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":615000,"percentOfClass":9.9,"filedAt":"2026-03-09"},{"accessionNo":"0000935836-26-000148","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock","eventDate":"2026-02-27","reportingPerson":"Logos Global Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":615000,"percentOfClass":9.9,"filedAt":"2026-03-09"},{"accessionNo":"0000935836-26-000148","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock","eventDate":"2026-02-27","reportingPerson":"Logos Global Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":615000,"percentOfClass":9.9,"filedAt":"2026-03-09"},{"accessionNo":"0000921895-26-000474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":768200,"percentOfClass":9.99,"filedAt":"2026-02-17"},{"accessionNo":"0000921895-26-000474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":768200,"percentOfClass":9.99,"filedAt":"2026-02-17"},{"accessionNo":"0000921895-26-000474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":768200,"percentOfClass":9.99,"filedAt":"2026-02-17"},{"accessionNo":"0001738048-26-000032","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":692959,"percentOfClass":9.9,"filedAt":"2026-02-17"},{"accessionNo":"0001738048-26-000032","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":692959,"percentOfClass":9.9,"filedAt":"2026-02-17"},{"accessionNo":"0001738048-26-000032","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":692959,"percentOfClass":9.9,"filedAt":"2026-02-17"},{"accessionNo":"0001738048-26-000032","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":692959,"percentOfClass":9.9,"filedAt":"2026-02-17"},{"accessionNo":"0001738048-26-000032","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":692959,"percentOfClass":9.9,"filedAt":"2026-02-17"},{"accessionNo":"0001493215-26-000052","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"RTW Investments, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":650968,"percentOfClass":9.9,"filedAt":"2026-02-17"},{"accessionNo":"0001738048-26-000032","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":692959,"percentOfClass":9.9,"filedAt":"2026-02-17"},{"accessionNo":"0001738048-26-000032","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":692959,"percentOfClass":9.9,"filedAt":"2026-02-17"},{"accessionNo":"0000921895-26-000474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":761815,"percentOfClass":9.9,"filedAt":"2026-02-17"},{"accessionNo":"0001493215-26-000052","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":650968,"percentOfClass":9.9,"filedAt":"2026-02-17"},{"accessionNo":"0001193125-26-054537","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":569308,"percentOfClass":9.1,"filedAt":"2026-02-17"},{"accessionNo":"0001193125-26-054537","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":569308,"percentOfClass":9.1,"filedAt":"2026-02-17"},{"accessionNo":"0001193125-26-054537","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":569308,"percentOfClass":9.1,"filedAt":"2026-02-17"},{"accessionNo":"0000921895-26-000474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":596433,"percentOfClass":7.8,"filedAt":"2026-02-17"},{"accessionNo":"0000921895-26-000474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":596433,"percentOfClass":7.8,"filedAt":"2026-02-17"},{"accessionNo":"0000902664-26-001129","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":423415,"percentOfClass":6.8,"filedAt":"2026-02-17"},{"accessionNo":"0000902664-26-001129","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":423415,"percentOfClass":6.8,"filedAt":"2026-02-17"},{"accessionNo":"0000902664-26-001129","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":423415,"percentOfClass":6.8,"filedAt":"2026-02-17"},{"accessionNo":"0000929638-26-000667","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"EASTON JEFF","reportingCik":null,"personType":"IN","sharesOwned":442480,"percentOfClass":6.62,"filedAt":"2026-02-17"},{"accessionNo":"0000929638-26-000667","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Lind Global Fund II LP","reportingCik":null,"personType":"PN","sharesOwned":442480,"percentOfClass":6.62,"filedAt":"2026-02-17"},{"accessionNo":"0000929638-26-000667","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Lind Global Partners II LLC","reportingCik":null,"personType":"OO","sharesOwned":442480,"percentOfClass":6.62,"filedAt":"2026-02-17"},{"accessionNo":"0001943462-26-000004","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Dellora Investments LP","reportingCik":null,"personType":"IA,HC","sharesOwned":401071,"percentOfClass":6.4,"filedAt":"2026-02-17"},{"accessionNo":"0001943462-26-000004","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Kevin Pyun","reportingCik":null,"personType":"IN,HC","sharesOwned":401071,"percentOfClass":6.4,"filedAt":"2026-02-17"},{"accessionNo":"0001943462-26-000004","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Dellora Investments Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":355257,"percentOfClass":5.7,"filedAt":"2026-02-17"},{"accessionNo":"0000921895-26-000474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":165382,"percentOfClass":2.3,"filedAt":"2026-02-17"},{"accessionNo":"0000921895-26-000474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":165382,"percentOfClass":2.3,"filedAt":"2026-02-17"},{"accessionNo":"0000921895-26-000474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17"},{"accessionNo":"0000921895-26-000474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17"},{"accessionNo":"0000895421-26-000063","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":596376,"percentOfClass":9.6,"filedAt":"2026-02-12"},{"accessionNo":"0000895421-26-000063","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Morgan Stanley Capital Services LLC","reportingCik":null,"personType":"BD,CO","sharesOwned":592316,"percentOfClass":9.5,"filedAt":"2026-02-12"},{"accessionNo":"0001193125-25-331003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-18","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":439142,"percentOfClass":7,"filedAt":"2025-12-23"},{"accessionNo":"0001193125-25-331003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-18","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":439142,"percentOfClass":7,"filedAt":"2025-12-23"},{"accessionNo":"0001193125-25-331003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-18","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":439142,"percentOfClass":7,"filedAt":"2025-12-23"},{"accessionNo":"0001274173-25-000344","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-11-28","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":623733,"percentOfClass":9.99,"filedAt":"2025-12-08"},{"accessionNo":"0001193125-25-309832","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-30","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":967600,"percentOfClass":15.5,"filedAt":"2025-12-05"},{"accessionNo":"0001193125-25-309832","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-30","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":967600,"percentOfClass":15.5,"filedAt":"2025-12-05"},{"accessionNo":"0000902664-25-005003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2024-09-30","reportingPerson":"Ryan Wilder","reportingCik":null,"personType":"HC,IN","sharesOwned":2470096,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0000902664-25-005003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2024-09-30","reportingPerson":"Vestal Point Capital, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2470096,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0001738048-25-000026","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":552970,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0001738048-25-000026","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":552970,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0001738048-25-000026","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":552970,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0001738048-25-000026","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":552970,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0001738048-25-000026","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":552970,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0001738048-25-000026","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":552970,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0001738048-25-000026","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":552970,"percentOfClass":9.9,"filedAt":"2025-11-14"},{"accessionNo":"0000929638-25-004298","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Lind Global Partners II LLC","reportingCik":null,"personType":"OO","sharesOwned":442480,"percentOfClass":8.8,"filedAt":"2025-11-14"},{"accessionNo":"0000929638-25-004298","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Lind Global Fund II LP","reportingCik":null,"personType":"PN","sharesOwned":442480,"percentOfClass":8.8,"filedAt":"2025-11-14"},{"accessionNo":"0000929638-25-004298","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"EASTON JEFF","reportingCik":null,"personType":"IN","sharesOwned":442480,"percentOfClass":8.8,"filedAt":"2025-11-14"},{"accessionNo":"0001104659-25-107035","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":313712,"percentOfClass":6.9,"filedAt":"2025-11-05"},{"accessionNo":"0001104659-25-107035","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":313712,"percentOfClass":6.9,"filedAt":"2025-11-05"},{"accessionNo":"0001104659-25-107035","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":313712,"percentOfClass":6.9,"filedAt":"2025-11-05"},{"accessionNo":"0001104659-25-107035","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":313712,"percentOfClass":6.9,"filedAt":"2025-11-05"},{"accessionNo":"0000902664-25-004624","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-22","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":339633,"percentOfClass":7.4,"filedAt":"2025-10-29"},{"accessionNo":"0000902664-25-004624","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-22","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":339633,"percentOfClass":7.4,"filedAt":"2025-10-29"},{"accessionNo":"0000902664-25-004624","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"TENAX THERAPEUTICS, INC.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-22","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":339633,"percentOfClass":7.4,"filedAt":"2025-10-29"},{"accessionNo":"0001193125-25-233496","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":967600,"percentOfClass":21.2,"filedAt":"2025-10-07"},{"accessionNo":"0001193125-25-233496","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":967600,"percentOfClass":21.2,"filedAt":"2025-10-07"},{"accessionNo":"0002005369-25-000052","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Raymond Debbane","reportingCik":null,"personType":"IN","sharesOwned":427141,"percentOfClass":9.4,"filedAt":"2025-10-02"},{"accessionNo":"0002005369-25-000052","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Invus Public Equities Advisors, LLC","reportingCik":null,"personType":"OO","sharesOwned":366143,"percentOfClass":8,"filedAt":"2025-10-02"},{"accessionNo":"0002005369-25-000052","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Siren, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":366143,"percentOfClass":8,"filedAt":"2025-10-02"},{"accessionNo":"0002005369-25-000052","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Invus Global Management, LLC","reportingCik":null,"personType":"OO","sharesOwned":366143,"percentOfClass":8,"filedAt":"2025-10-02"},{"accessionNo":"0002005369-25-000052","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Invus Public Equities, L.P.","reportingCik":null,"personType":"PN","sharesOwned":366143,"percentOfClass":8,"filedAt":"2025-10-02"},{"accessionNo":"0002005369-25-000052","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Avicenna Life Sci Master GP LLC","reportingCik":null,"personType":"OO","sharesOwned":60998,"percentOfClass":1.3,"filedAt":"2025-10-02"},{"accessionNo":"0002005369-25-000052","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Avicenna Life Sci Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":60998,"percentOfClass":1.3,"filedAt":"2025-10-02"},{"accessionNo":"0002005369-25-000052","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000034956","issuerName":"Tenax Therapeutics, Inc.","ticker":"TENX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Ulys, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":60998,"percentOfClass":1.3,"filedAt":"2025-10-02"}],"updatedAt":"2026-09-19T08:13:27.117Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}